Perrigo Company PLC (PRGO)

NYSE: PRGO · IEX Real-Time Price · USD
42.58
-0.40 (-0.93%)
Aug 8, 2022 4:00 PM EDT - Market closed
-0.93%
Market Cap 5.73B
Revenue (ttm) 4.20B
Net Income (ttm) -109.40M
Shares Out 134.55M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE 18.08
Dividend $1.00 (2.35%)
Ex-Dividend Date Sep 1, 2022
Volume 1,589,865
Open 43.05
Previous Close 42.98
Day's Range 42.51 - 43.59
52-Week Range 31.32 - 50.90
Beta 0.91
Analysts Buy
Price Target 49.64 (+16.6%)
Earnings Date Aug 9, 2022

About PRGO

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vit... [Read more...]

Industry Pharmaceuticals
IPO Date Dec 16, 1991
CEO Uwe Rohrhoff
Employees 9,900
Stock Exchange NYSE
Ticker Symbol PRGO
Full Company Profile

Financial Performance

In 2021, PRGO's revenue was $4.14 billion, an increase of 1.24% compared to the previous year's $4.09 billion. Losses were -$68.90 million, -57.63% less than in 2020.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for PRGO stock is "Buy." The 12-month stock price forecast is 49.64, which is an increase of 16.58% from the latest price.

Price Target
$49.64
(16.58% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PERRIGO ANNOUNCES QUARTERLY DIVIDEND

DUBLIN , Aug. 2, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividen...

PERRIGO TO RELEASE SECOND QUARTER 2022 FINANCIAL RESULTS ON AUGUST 9, 2022

DUBLIN , July 27, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it will release its second quarter 2022 financial results...

Perrigo (PRGO) Unit Files for OTC Birth Control Pill With FDA

The FDA's potential approval of Perrigo (PRGO) unit, HRA Pharma's OTC birth control pills can make the drug the first of its kind to be made available without prescription in the United States.

FDA Might Authorize First Over-the-Counter Birth Control Pill

A company is asking the FDA to make its progestin-only pill available without prescription.

FDA to review first ever over-the-counter birth control pill

The application from the Paris-based HRA Pharma comes on the back of the U.S. Supreme Court's decision in June to overturn the 1973 Roe v. Wade case that legalized abortion nationwide

FDA to consider pharma company's application for over-the-counter birth control pill

HRA executives expect a decision by the FDA in the first half of 2023

Perrigo unit submits approval application to FDA for OTC birth control pill

Perrigo Company said on Monday its unit has submitted an application to the U.S. Food and Drug Administration (FDA) for approval of an over-the-counter (OTC) birth control pill.

Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill

DUBLIN and ALLEGAN, Mich. , July 11, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that HRA Pharma, a Perrigo company, ...

Why Is Perrigo (PRGO) Up 13.4% Since Last Earnings Report?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?

Perrigo Stock is a Second Half Expansion Play

Self-care health and wellness products make Perrigo (NASDAQ: PRGO) stock has been recovering well off its $31.22 bottom.

Biden to meet with CEOs of baby-formula makers as shortage worsens

President Joe Biden on Wednesday is slated to meet with executives from baby-formula makers, with the huddle coming as new data suggest that the country's formula shortage is deepening.

Other symbols: NSRGYRBGLY

PERRIGO PROMOTES ALISON IVES TO ROLE OF CHIEF SCIENTIFIC OFFICER

DUBLIN , June 1, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) today announced that Ms. Alison Ives has been promoted to Executive Vice President and Chief Scientific Officer.

PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR OMEPRAZOLE MAGNESIUM DELAYED-RELEASE MINI CAPSULES

DUBLIN , May 26, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug...

PERRIGO TO PRESENT AT UPCOMING CONSUMER INVESTOR CONFERENCES

DUBLIN , May 19, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Murray S. Kessler and CFO Eduardo Bezer...

Exclusive-Maker of Walmart, Amazon store-brand infant formulas expects shortages through rest of 2022

Perrigo Company PLC, which makes store-brand baby formulas for retailers including Walmart Inc and Amazon.com Inc expects shortages and heightened demand to last for the "balance of the year," said CEO ...

Perrigo Shares Pop On Raised FY22 Guidance Surpassing Consensus Estimates

Perrigo Company plc's (NYSE: PRGO) Q1 FY22 sales increased 6.4% Y/Y to $1.07 billion, almost in line with the consensus of $1.1 billion. The growth was led by strong consumer demand, particularly for co...

Perrigo (PRGO) Q1 Earnings Miss, Margins Hurt by Higher Costs

Perrigo (PRGO) reports mixed first-quarter 2022 results. Sales of cough/cold products continue the strong rebound during the reported quarter.

Perrigo (PRGO) Q1 Earnings Lag Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of -21.43% and 1.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Perrigo shares slide 4% premarket after company swings to Q1 loss

Perrigo PLC shares PRGO, +0.37% slid 4% in premarket trade Wednesday, after the personal self-care product maker swung to a loss for the first quarter and fell short of estimates. The Dublin-based Perri...

PERRIGO REPORTS FIRST QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS, RAISES GUIDANCE

DUBLIN, May 11, 2022 /PRNewswire/ -- Highlights: Perrigo achieved first quarter net sales of $1.1 billion, an increase of 6.4% versus the prior year quarter. Organic(1) net sales increased 9.7%, led by ...

PERRIGO ANNOUNCES PLANNED LEADERSHIP SUCCESSION

Mr. Eduardo G. Bezerra named EVP, Chief Financial Officer Mr.

Earnings Preview: Perrigo (PRGO) Q1 Earnings Expected to Decline

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PERRIGO COMPLETES THE ACQUISITION OF HRA PHARMA

DUBLIN , May 2, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products , today announced that on April 29, 2022 it completed the previously announced ac...

PERRIGO ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA

DUBLIN , April 28, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that the closing date of the previously announced acquisition...